Health Trials

Warm Autoimmune Hemolytic Anemia (WAIHA)

2

Review clinical trials related to Warm Autoimmune Hemolytic Anemia (WAIHA). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA

A Phase 1b/2a, open-label dose escalation and dose expansion study of subcutaneously (SC) administered velinotamig for the treatment of adults with relapsing and refractory immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA) to evaluate safety and tolerability.

Participants needed: 72
Trial details
Phase: Phase 1, Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Cullinan Therapeutics Inc.Updated: Jul 31, 2026Locations: 1
Eligibility criteria

Age ≥18 to 80 years [+9]

Pregnant or lactating women [+9]

Read more
Status: Recruiting

Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

This is a single-arm, open-label, multicenter, ascending dose Phase 1/2 trial evaluating the safety and preliminary efficacy of CTX112 or Zugocabtagene geleucel (zugo-cel) in adult participants with relapsed/refractory primary Immune Thrombocytopenia (ITP) and relapsed/refractory primary Warm Autoimmune Hemolytic Anemia (wAIHA).

Participants needed: 60
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: CRISPR Therapeutics AGUpdated: Jul 22, 2026Locations: 10
Eligibility criteria

Age ≥18 years. [+5]

Prior treatment with anti-CD19 therapy or any gene therapy or genetically modifi... [+10]

Read more